298.25
Medpace Holdings Inc stock is traded at $298.25, with a volume of 327.94K.
It is down -1.89% in the last 24 hours and down -3.84% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$304.00
Open:
$300
24h Volume:
327.94K
Relative Volume:
0.69
Market Cap:
$8.52B
Revenue:
$2.16B
Net Income/Loss:
$416.39M
P/E Ratio:
22.77
EPS:
13.1
Net Cash Flow:
$540.93M
1W Performance:
+0.59%
1M Performance:
-3.84%
6M Performance:
-13.78%
1Y Performance:
-24.32%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MEDP
Medpace Holdings Inc
|
298.25 | 8.52B | 2.16B | 416.39M | 540.93M | 13.10 |
![]()
TMO
Thermo Fisher Scientific Inc
|
402.76 | 151.71B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
200.67 | 140.29B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
522.70 | 42.21B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
117.08 | 32.89B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
156.89 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
Mar-24-25 | Initiated | Leerink Partners | Market Perform |
Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Sep-27-24 | Downgrade | UBS | Buy → Neutral |
Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
Aug-01-24 | Initiated | Truist | Hold |
May-29-24 | Initiated | TD Cowen | Buy |
May-28-24 | Initiated | Mizuho | Buy |
Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
Mar-18-24 | Initiated | Deutsche Bank | Hold |
Feb-15-24 | Upgrade | UBS | Neutral → Buy |
Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
Oct-27-22 | Upgrade | UBS | Sell → Neutral |
Sep-07-22 | Initiated | UBS | Sell |
May-24-22 | Initiated | Guggenheim | Neutral |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Oct-02-20 | Upgrade | Truist | Hold → Buy |
Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
Sep-17-18 | Initiated | SunTrust | Hold |
Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-29-17 | Initiated | Raymond James | Mkt Perform |
Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 48% Discount? - simplywall.st
Medpace: An Excellent Company In A Context Of Uncertainty (NASDAQ:MEDP) - Seeking Alpha
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
truist securities maintains hold rating on medpace stock By Investing.com - Investing.com Canada
truist securities maintains hold rating on medpace stock - Investing.com
Why Medpace Holdings Shares Are Under Pressure - TipRanks
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
Is Medpace Stock Worth the Hype? Here's What Analysts Think. - AOL.com
Is Medpace Stock Worth The Hype? Here's What Analysts Think. - Barchart.com
Investing in Medpace Holdings (NASDAQ:MEDP) five years ago would have delivered you a 211% gain - simplywall.st
Deutsche Bank AG Sells 5,583 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Insider Monkey
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
William Blair Remains a Hold on Medpace Holdings (MEDP) - The Globe and Mail
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Rating of “Hold” from Analysts - Defense World
Medpace Holdings Approves Key Proposals at Annual Meeting - TipRanks
RNA Therapy Clinical Trials Market Top Companies StudyCharles - openPR.com
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Medpace Holdings Surpasses Expectations with Q1 2025 EarningsNews and Statistics - IndexBox
MEDP STOCK ALERT: Levi & Korsinsky Notifies Medpace Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)? - Yahoo Finance
Medpace Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking - simplywall.st
Hsbc Holdings PLC Has $566,000 Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN
Positive Long-Term Outlook for Narrow-Moat Medpace Despite Macroeconomic Pressure in Near Term - Morningstar
Press Release Distribution & PR Platform - ACCESS Newswire
Medpace (MEDP) Faces Earnings Volatility Amid Tariff Concerns - GuruFocus
Medpace drops despite Q1 beat amid disappointing performance metrics - MSN
William Blair Issues Negative Outlook for Medpace Earnings - Defense World
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus
William Blair Forecasts Medpace’s Q3 Earnings (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript - MSN
Medpace to increase size of stock buyback program by $1B - MSN
William Blair Downgrades Medpace Holdings (BMV:MEDP) - Nasdaq
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Ho - GuruFocus
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus
Truist Cuts Price Target on Medpace Holdings to $300 From $333, Keeps Hold Rating - marketscreener.com
Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outloo - GuruFocus
Medpace Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):